Carol Cronenberger Selected Research

Intravenous Infusions

12/2013

Safety and pharmacokinetics of PF-04360365 following a single-dose intravenous infusion in Japanese subjects with mild-to-moderate Alzheimer's disease: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carol Cronenberger Research Topics

Disease

7	Rheumatoid Arthritis 06/2022 - 01/2018
2	Hypersensitivity (Allergy) 01/2018 - 12/2013
2	Alzheimer Disease (Alzheimer's Disease) 09/2017 - 12/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Injection Site Reaction 01/2018
1	Myocardial Infarction 01/2018
1	Opportunistic Infections (Opportunistic Infection) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Headache (Headaches) 09/2017

Drug/Important Bio-Agent (IBA)

7	Biosimilar PharmaceuticalsIBA 06/2022 - 01/2018
4	PF-06410293IBA 06/2022 - 01/2018
4	Adalimumab (Humira)FDA Link 06/2022 - 01/2018
2	GP1111IBA 04/2020 - 01/2019
2	Infliximab (Remicade)FDA Link 04/2020 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 09/2017 - 12/2013
2	ponezumabIBA 09/2017 - 12/2013
1	Pharmaceutical PreparationsIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Rituximab (Mabthera)FDA Link 11/2018
1	Biological ProductsIBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2018
1	Immunoglobulin G (IgG)IBA 12/2013
1	AntibodiesIBA 12/2013

Therapy/Procedure

2	Activities of Daily Living (ADL) 06/2022 - 01/2021
2	Therapeutics 01/2021 - 04/2020
1	Intravenous Infusions 12/2013